The latest company updates, scientific publications, and captivating articles.
ISC 2026 Reinforces the Case for AI-Driven Pupillometry in Stroke Care
Exploring how quantitative pupillometry enhances stroke monitoring and improves early detection of neurological decline.
Solvemed’s access to the $300m Isambard-AI supercomputer allows researchers to run medical AI experiments that were previously impossible due to computational limits.
We focus on building trust, ensuring robust security, and delivering reliable performance so hospitals can depend on our software as a medical device in high-stakes clinical environments.
Stroke costs are projected to reach $94.3 billion by 2035, driving healthcare leaders to adopt AI solutions for this growing challenge.
Simple lighting changes could impact neurological assessments: Study reveals how ICU environments might influence automated pupil monitoring accuracy.
iPhone-based pupillometry reduces assessment time from 100 to 21 seconds: Automated documentation eliminates manual steps in ICU monitoring
Research validates environmental factors in automated pupillometry: Charlene Ong study reveals ambient light impact on neurointensive care measurements.
From stroke triage to continuous brain monitoring, AI is reshaping how neurocritical care teams work in neurological emergencies. Advanced algorithms now deliver faster, more objective, data-driven assessments.
A proven pioneer in medical technology and recognized expert in physiological signal analysis, Marek has played a pivotal role as Solvemed's CTO. His transition to the Board marks a strategic inflection point as the company scales its AI Pupillometry System toward broader clinical adoption.
Solvemed demonstrates AI-driven smartphone-based pupillometry technology for improved stroke care at ISC 2025.
Solvemed showcases PuRe™ Pupillometer technology at premier neurocritical care conference, demonstrating breakthrough AI-powered medical device for ICU applications.
Solvemed has completed a clinical trial using the PuRe™ Pupillometer, demonstrating the potential of AI-powered quantitative pupillometry for advancing neurological diagnostics.
Solvemed expanded its international presence by partnering with the British Association of Critical Care Nurses conference in Nottingham, following successful showcases at major US medical conferences.
Our team connects with emergency nursing professionals at ENA2023, showcasing AI-powered PuRe™ Pupillometer for critical triage assessments.
Solvemed showcases AI-driven neuromonitoring technology at CHEST 2023, connecting with global critical care and pulmonary specialists.
Ambient light creates measurement errors in neurointensive care: New lighting-corrected pupillometry prevents misclassification of critically ill patients
In today’s fast-paced clinical environment, swiftly and accurately evaluating a patient's neurological status is vital. Yet traditional pupillary assessments — based on visual observation — can be inconsistent and prone to subjective interpretation. To solve this long-standing challenge, Solvemed Inc. introduces a breakthrough in neurological evaluation: the Pupil Reactivity (PuRe) score.
Solvemed strengthens its commitment to supporting neuro-ophthalmic care on Earth and in space.
.png)
